Association of forced expiratory volume with disease duration and sputum neutrophils in chronic asthma

American Journal of Medicine

Volumn 112, Issue 6, 2002, Pages 446-452

  Little, Stuart A ^a   MacLeod, Kirsten J ^b   Chalmers, George W ^a   Love, Janet G ^b   McSharry, Charles ^a   Thomson, Neil C ^a,b  

^a Department of Respiratory Medicine ^*  (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Chronic asthma; Induced sputum neutrophils; Irreversible airflow obstruction

Indexed keywords

FLUTICASONE; MYELOPEROXIDASE; PREDNISOLONE; SALBUTAMOL;

ADULT; AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; CELL COUNT; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LEUKOCYTE ACTIVATION; LUNG FUNCTION; MAJOR CLINICAL STUDY; NEUTROPHIL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SMOKING; SMOKING CESSATION; SPUTUM ANALYSIS;

ADMINISTRATION, TOPICAL; ADULT; ALBUTEROL; ANDROSTADIENES; ANTI-INFLAMMATORY AGENTS; ASTHMA; BRONCHODILATOR AGENTS; CHRONIC DISEASE; CLINICAL TRIALS; FEMALE; FORCED EXPIRATORY VOLUME; GLUCOCORTICOIDS; HUMANS; LEUKOCYTE COUNT; LINEAR MODELS; MALE; MIDDLE AGED; NEUTROPHILS; PREDNISOLONE; SPIROMETRY; SPUTUM; TIME FACTORS;

EID: 0037090945     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(02)01047-1     Document Type: Article

References (33)

1. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma
2. Mucosal inflammation in asthma
3. Asthma - From bronchoconstriction to airways inflammation and remodeling
4. Outcome of asthma: Longitudinal changes in lung function
5. Eosinophilic inflammation in asthma
6. Activation of neutrophils and monocytes after allergen- and histamine-induced bronchoconstriction
7. Host-defence mechanisms responsible for lung injury
8. Neutrophil chemotactic activity in acute severe asthma (status asthmaticus)
9. Bronchoalveolar neutrophilia during late asthmatic reactions induced by Toluene Diisocyanate
10. Number and activity of inflammatory cells in bronchoalveolar lavage fluid in asthma and their relation to airway responsiveness
11. Sudden-onset fatal asthma: A distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa?
12. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation
13. Bronchial neutrophilia in patients with noninfectious status asthmaticus
14. Increased neutrophil numbers and IL-8 levels in airway secretions in acute severe asthma - Clinical and biological significance
15. Bronchoscopic evaluation of severe asthma - Persistent inflammation associated with high dose glucocorticoids
16. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics
17. Neutrophilic inflammation in severe persistent asthma
18. Heterogeneity of airway inflammation in persistent asthma: Evidence of neutrophilic inflammation and increased sputum interleukin-8
19. Standardization of spirometry - 1987 Update
20. Standardization lung of function testing
21. Standardised lung function testing. Report of Working Party for the European Community for Steel and Coal
22. Use of induced sputum cell counts to investigate airway inflammation in asthma
23. The evaluation of a cell dispersion method of sputum examination
24. Electronic cell counting to measure total cell numbers in bronchoalveolar lavage fluid
25. Measurement of inflammatory indices in induced sputum: Effects of selection of sputum to minimize salivary contamination
26. Asthma and irreversible airflow obstruction
27. A 10 year follow up of 180 adults with bronchial asthma: Factors important for the decline in lung function
28. Nonreversible airflow obstruction in life-long nonsmokers with moderate to severe asthma
29. A 15-year follow-up study of ventilatory function in adults with asthma
30. Physiologic consequences of long-term inflammation
31. Bronchoalveolar cell profiles of asthmatic and nonasthmatic subjects
32. Changes in the proportions of bronchoalveolar lymphocytes, neutrophils and basophilic cells and the release of histamine and leukotrienes from bronchoalveolar cells in patients with steroid-dependent intractable asthma
33. Elevated secretion of myeloperoxidase by neutrophils from asthmatic patients: The effect of immunotherapy